Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    CEFAZOLIN AND DEXTROSE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 139Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 ACS DOBFAR SPA
    Italy
    		 ACS DOBFAR S.P.A. Tribiano IT R1-CEP 1996-083 - Rev 06 Cefazolin sodium, Sterile 2019-06-17 Valid Chemical 988
    29/11/2025 Amifarma S.L. ES 08389 Palafolls Barcelona
    Spain
    		 Amifarma S.L. Palafolls (Barcelona) ES R0-CEP 1998-054 - Rev 03 Cefazolin sodium, Sterile 2004-10-01 Withdrawn by Holder Chemical 2005-05-30 988